In two cohorts of CKD patients Tripepi et al. found a strong competitive interaction between FGF23 and ADMA suggesting that FGF23 is a modifier for ADMA levels, leading to dysregulation of the nitric oxide system associated with CKD progression [115]. The gene discussed is FGF23; the disease is chronic kidney disease.